Lonestar Medicines, Inc. — Form D

Lonestar Medicines, Inc. of BOSTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2026-02-23. The offering totals $45.0M, of which $25.0M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2026-02-23
• Form: D
• Accession: 0002111460-26-000001
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $45.0M
• Amount sold: $25.0M
• Remaining: $20.0M
• Investors: 4
• Date of first sale: 2026-01-12
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-574347

Issuer

• Name: Lonestar Medicines, Inc.
• CIK: 0002111460
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2025
• Address: 200 BERKELEY STREET, BOSTON, MA, 02116
• Phone: 518-313-0994

Officers, directors & promoters (8)

More

• CIK 2111460 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search